Synthesis and SAR of 8-aza-quinoxalin-2(1H)-one as corticotropin-releasing factor-1 receptor antagonists

被引:0
|
作者
Dasgupta, Bireshwar [1 ]
Dzierba, Carolyn D. [1 ]
Sielecki, Thais M. [1 ]
Galka, Amy [1 ]
Johnson, Tricia L. [1 ]
Takvorian, Amy G. [1 ]
Rafalski, Maria [1 ]
Kasireddy-Polam, Padmaja [1 ]
Vig, Shikha [1 ]
Arvanitis, Argyrios G. [1 ]
Zhang, Ge [2 ]
Molski, Thaddeus F. [2 ]
Zaczek, Robert C. [2 ]
Combs, Andrew P. [1 ]
Gilligan, Paul J. [1 ]
Trainor, George [4 ]
Bronson, Joanne J. [1 ]
Macor, John E. [3 ]
机构
[1] Bristol Myers Squibb Co, Res & Dev, Neurosci Discovery Chem, Wallingford, CT 06492 USA
[2] Bristol Myers Squibb Co, Res & Dev, Neurosci Discovery Biol, Wallingford, CT 06492 USA
[3] Bristol Myers Squibb Co, Res & Dev, Neurosci Chem, Wallingford, CT 06492 USA
[4] Bristol Myers Squibb Co, Discovery Chem, Res & Dev, Princeton, NJ 08543 USA
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
85-MEDI
引用
收藏
页数:1
相关论文
共 50 条
  • [11] Synthesis and structure-activity relationships of N3-pyridylpyrazinones as corticotropin-releasing factor-1 (CRF1) receptor antagonists
    Hartz, Richard A.
    Ahuja, Vijay T.
    Schmitz, William D.
    Molski, Thaddeus F.
    Mattson, Gail K.
    Lodge, Nicholas J.
    Bronson, Joanne J.
    Macor, John E.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (06) : 1890 - 1894
  • [12] Design, synthesis, and SAR of 2-dialkylamino-4-arylpyrimidines as potent and selective corticotropin-releasing factor1 (CRF1) receptor antagonists
    Huang, CQ
    Grigoriadis, DE
    Liu, ZY
    McCarthy, JR
    Ramphal, J
    Webb, T
    Whitten, JP
    Xie, MY
    Chen, C
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (09) : 2083 - 2086
  • [13] Dihydropyridopyrazinones and dihydropteridinones as corticotropin-releasing factor-1 receptor antagonists: Structure-activity relationships and computational modeling
    Dzierba, Carolyn D.
    Tebben, Andrew J.
    Wilde, Richard G.
    Takvorian, Amy G.
    Rafalski, Maria
    Kasireddy-Polam, Padmaja
    Klaczkiewicz, John D.
    Pechulis, Anthony D.
    Davis, Amy L.
    Sweet, Mark P.
    Woo, Alex M.
    Yang, Zhicai
    Ebeltoft, Sarah M.
    Molski, Thaddeus F.
    Zhang, Ge
    Zaczek, Robert C.
    Trainor, George L.
    Combs, Andrew P.
    Gilligan, Paul J.
    JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (09) : 2269 - 2272
  • [14] Synthesis and structure-activity relationships of 8-substituted-2-aryl-5-alkylaminoquinolines: Potent, orally active corticotropin-releasing factor-1 receptor antagonists
    Takeda, Kunitoshi
    Terauchi, Taro
    Hashizume, Minako
    Shikata, Kohdoh
    Taguchi, Ryota
    Murata-Tai, Kaoru
    Fujisawa, Masae
    Takahashi, Yoshinori
    Shin, Kogyoku
    Ino, Mitsuhiro
    Shibata, Hisashi
    Yonaga, Masahiro
    BIOORGANIC & MEDICINAL CHEMISTRY, 2012, 20 (22) : 6559 - 6578
  • [15] Synthesis and Pharmacological Characterization of Novel Druglike Corticotropin-Releasing Factor 1 Antagonists
    Di Fabio, Romano
    St-Denis, Yves
    Sabbatini, Fabio M.
    Andreotti, Daniele
    Arban, Roberto
    Bernasconi, Giovanni
    Braggio, Simone
    Blaney, Frank E.
    Capelli, Anna M.
    Castiglioni, Emiliano
    Di Modugno, Enza
    Donati, Daniele
    Fazzolari, Elettra
    Ratti, Emiliangelo
    Feriani, Aldo
    Contini, Stefania
    Gentile, Gabriella
    Ghirlanda, Damiano
    Provera, Stefano
    Marchioro, Carla
    Roberts, Karen L.
    Mingardi, Anna
    Mattioli, Mario
    Nalin, Arnaldo
    Pavone, Francesca
    Spada, Simone
    Trist, David G.
    Worby, Angela
    JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (23) : 7370 - 7379
  • [16] Predictive QSAR modeling of substituted Phenylpyrazinones as corticotropin-releasing factor-1 (CRF1) receptor antagonists: computational approach
    Sharma M.C.
    Netw. Model. Anal. Health Informatics Bioinformatics, 1 (1-15): : 1 - 15
  • [17] Corticotropin-releasing factor type-1 receptor antagonists: The next class of antidepressants?
    Nielsen, DM
    LIFE SCIENCES, 2006, 78 (09) : 909 - 919
  • [18] Design, synthesis and structure-activity relationships of 5-alkylaminoquinolines: Potent, orally active corticotropin-releasing factor-1 receptor antagonists
    Takeda, Kunitoshi
    Terauchi, Taro
    Hashizume, Minako
    Shikata, Kohdoh
    Taguchi, Ryota
    Murata-Tai, Kaoru
    Fujisawa, Masae
    Takahashi, Yoshinori
    Shin, Kogyoku
    Ino, Mitsuhiro
    Shibata, Hisashi
    Yonaga, Masahiro
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 247
  • [19] Blocking corticotropin-releasing factor-2 receptors, but not corticotropin-releasing factor-1 receptors or glucocorticoid feedback, disrupts the development of conditioned defeat
    Cooper, Matthew A.
    Huhman, Kim L.
    PHYSIOLOGY & BEHAVIOR, 2010, 101 (04) : 527 - 532
  • [20] Design and synthesis of tricyclic imidazo[4,5-b]pyridin-2-ones as corticotropin-releasing factor-1 antagonists
    Guo, ZQ
    Tellew, JE
    Gross, RS
    Dyck, B
    Grey, J
    Haddach, M
    Kiankarimi, M
    Lanier, M
    Li, BF
    Luo, ZY
    McCarthy, JR
    Moorjani, M
    Saunders, J
    Sullivan, R
    Zhang, XH
    Zamani-Kord, S
    Grigoriadis, DE
    Crowe, PD
    Chen, TK
    Williams, JP
    JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (16) : 5104 - 5107